Oncology MRI

Emerging research suggests that combining pre-biopsy magnetic resonance imaging (MRI) with prostate-specific antigen (PSA) testing more than triples the specificity rate for detecting clinically significant prostate cancer in comparison to sole reliance on a PSA level greater than or equal to 4 ng/mL.

Emerging research suggests that the contrast-enhanced, in-phase Dixon sequence may be the most optimal sequence for detecting biopsy clips on breast magnetic resonance imaging (MRI).

Greater imaging utilization has increased the prevalence of incidental findings or incidentalomas, but unclear clinical context and guidelines complicate management. Accordingly, these authors offer a thorough review of the literature and discuss new opportunities for improving interdisciplinary management strategies.

Catch up on the top radiology content of the past week.

Mild, moderate, or marked background parenchymal enhancement on surveillance magnetic resonance imaging (MRI) reportedly doubles the risk of second breast cancer in women who have had surgery for primary breast cancer.

Catch up on the top radiology content of the past week.

Researchers found the combination of magnetic resonance imaging (MRI) and contrast-enhanced mammography was nearly 22 percent more effective at detecting breast lesions than MRI-directed ultrasound.

Catch up on the top AI-related radiology content of the past month.

Noting that the machine learning model incorporating magnetic resonance imaging (MRI) had a higher mean area under the curve (AUC) than a model based solely on clinical features for predicting hepatocellular carcinoma recurrence, researchers said the study findings could have implications for refining liver transplant criteria.

Catch up on the top radiology content of the past week.

In comparison to neuroradiology assessment of brain magnetic resonance imaging (MRI) scans for tumor diagnosis, researchers found that adjunctive use of a deep learning system improved diagnostic accuracy by 12.4 percent and sensitivity by 33.5 percent in one test set of 300 patients.

The combination of magnetic resonance imaging (MRI) and computed tomography (CT) had a 63.83 percent sensitivity rate for tumor-infiltrated axillary lymph nodes in patients with breast cancer in comparison to a 36.11 percent sensitivity rate for the combination of mammography and sonography.

Catch up on the top radiology content of the past week.

The ProstatID, an adjunctive artificial intelligence software that radiologists can utilize with traditional magnetic resonance imaging (MRI), reportedly measures prostate gland volume, and suggests PI-RADS scoring of suspicious lesions.

Catch up on the top radiology content of the past week.

The imaging agent is approved for use in 50 countries in Europe and Asia, but is not currently approved in the US.

Catch up on the top radiology content of the past week.

A recently published prospective study comparing multiparametric magnetic resonance imaging (MRI) and micro-ultrasound found similar detection rates for prostate cancer.

Catch up on the top radiology content of the past week.

The artificial intelligence (AI) capabilities of the new software reportedly facilitate scanning times that are three times faster than conventional magnetic resonance image (MRI) scanners.

In their testing of eight commercially available filtering face piece (FFP3) respirators commonly utilized during the COVID-19 pandemic, researchers deemed that five of the face masks that contained ferromagnetic materials were unsafe to use in and around magnetic resonance imaging (MRI) devices.

Catch up on the top radiology news of the past week.

Magnetic resonance imaging (MRI) had better accuracy than prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) “for detecting any grade of prostate cancer,” according to new study findings presented at the European Association of Urology Annual Congress (EAU22) in Amsterdam.

The new magnetic resonance imaging (MRI) device reportedly offers deep learning technologies and advanced processing of whole-body images in a cost-effective and lightweight model.

Calantric™ Digital Solutions reportedly offers artificial intelligence (AI)-powered apps, bolsters lesion detection, facilitates triage priorities and enhances workflow efficiency.

Catch up on the top radiology news of the past week.

The radiopharmaceutical is already approved for use in PET imaging in men with suspected prostate cancer recurrence.

As the iodinated contrast media shortage continues to have a significant adverse effect on radiology, these authors assess the pros and cons of emerging strategies and imaging alternatives.

Catch up on the top radiology content of the past week.

Despite increased use of preoperative magnetic resonance imaging (MRI) in recent years for patients undergoing surgery for prostate cancer, a study found that over 70 percent of a large Medicare population with prostate cancer did not have a preoperative MRI scan as of 2015.